Insmed Operating Cash Flow increased by 10.0% to -$222.74M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 15.0%, from -$262.09M to -$222.74M. Over 4 years (FY 2021 to FY 2025), Operating Cash Flow shows a downward trend with a 26.7% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$75.44M | -$75.45M | -$84.13M | -$105.16M | -$102.30M | -$89.83M | -$103.15M | -$146.30M | -$122.79M | -$136.33M | -$130.82M | -$184.04M | -$122.95M | -$180.92M | -$195.98M | -$262.09M | -$205.57M | -$219.76M | -$247.60M | -$222.74M |
| QoQ Change | — | -0.0% | -11.5% | -25.0% | +2.7% | +12.2% | -14.8% | -41.8% | +16.1% | -11.0% | +4.0% | -40.7% | +33.2% | -47.1% | -8.3% | -33.7% | +21.6% | -6.9% | -12.7% | +10.0% |
| YoY Change | — | — | — | — | -35.6% | -19.1% | -22.6% | -39.1% | -20.0% | -51.8% | -26.8% | -25.8% | -0.1% | -32.7% | -49.8% | -42.4% | -67.2% | -21.5% | -26.3% | +15.0% |